Thank you for visiting SEAK Therapeutics, LLC. This site is under construction and I hope you can come back to visit us again.
About SEAK Therapeutics LLC
SEAK Therapeutics LLC is a start up company founded in November 2018 by Dr. Wei Li. The goal of SEAK is to develop a new targeted small-molecule drug for cancers or neurological diseases where the target is expressed/over-activated.
Funding and Products
SEAK Therapeutics is still in its early stages of development, and we greatly appreciate the supports from the NIH SBIR/STTR grant programs, the LanuchTN matching grant programs, and other sources of funding.
SEAK Therapeutics welcomes Angel Investments and other supports. Please contact Dr. Wei Li at wli.uthsc@gmail.com for additional information. Thank you for your visit.
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Contact
Email: wli.uthsc@gmail.com